A Slovenian research organization has developed a method for controlled aggregation of microbial cells. The method is useful in different biotechnology fields such as plant and food biotechnology, fermentation, remediation, biofouling etc.
The signing of a partnership agreement between five international clusters and MultiHelix AB in June 2016 was the start of Twins' International MultiHelix, or in short TIM. TIM will facilitate investments and partnering, and represents collaboration in the life sciences and technologies between science parks and clusters in North America, Asia and Europe.
These clusters, science and technology parks have a joint vision to create an international...
The X-Europe Consortium brings together leading training, acceleration, events, and media companies from across Europe. Together we will link the developing regions of the Baltics and the Visegrad region to the wider European ecosystem, rebalancing the flow of socio-economic capital. Through the delivery of training, matchmaking & promotional services X-Europe will support 150 deeptech startups and help them to internationalise, grow across borders, and into...
An Ukrainian R&D company has developed a technology for the production of a new antiviral and antibacterial sorbent for respiratory protection, produced on the basis of thermally expanded graphite, instead of the activated carbon used today in manufactured respirators.
Scientists from a Polish university, who specialise in bio-immobilisation technologies and packaging materials, have developed the melamine-modified gelatine - a material for the production of films and coatings employed in food and pharmaceutical industries. The material is cheaper, more effective at preventing oxidation and photodegradation, and its production is safer for the environment than the other solutions.
A Spanish technology-based company which provides a wide range of products and services in the nanobiotechnology field has developed multimodal nanocarriers that can be used in drug delivery, targeted delivery for labelling, imaging and tracking.
A university spin-off in Northern Italy has developed a non toxic and non-cancerogenic fixative alternative to the use of formaline, that is a forbidden substance, to create Formalin-free hospitals, where thousands of health workers are now exposed to its effects.
Lazio Innova, as partner of the Enterprise Europe Network, is organising, together with Innovhub-SSI, Assobiotec - the Italian Association for the development of biotechnology - and Regione Lazio the 10th edition of IFIB - International Forum on Industrial Biotechnology and Bioeconomy - aimed at strengthening the bioeconomy network in the Euro-Mediterranean area and to promote partnerships.
A Spanish research group is looking for potential partners to apply for European projects focused in neuromuscular disorders, muscle regeneration/stem cells, age-related muscle-wasting disorders, fragility and exercise. The research group has over 20 years of experience in these research fields and in developing R&D funded projects.